EUVIMEDEUVIMED entdecken
Crossref

Evaluating gender effect in the generic bioequivalence studies by physiologically based pharmacokinetic modeling – A case study of dextromethorphan modified release tablets

Manoj Gundeti, Aditya Murthy iD, Shubham Jamdade, Tausif Ahmed iD

Biopharmaceutics & Drug Disposition · 2024

DOI: 10.1002/bdd.2389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, 2024. Verfasst von Manoj Gundeti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Global Clinical Management, IPDO, Dr Reddy's Laboratories Ltd, Hyderabad, India. Hauptthemen laut MEDLINE: Therapeutic Equivalency, Dextromethorphan, Drugs, Generic, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Dr Reddy's Laboratories Ltd, Hyderabad, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The United States Food and Drug Administration guidelines for the bioequivalence (BE) testing of the generic drug products suggests that there should be an equal proportion of male and female population in the BE study. Despite this requirement, many generic drug companies do not maintain the suggested proportion of female population in their studies. Several socio‐economic and cultural factors lead to lower participation of the females in the BE studies. More recently, the regulatory agencies across the globe are requesting the generic drug companies to demonstrate the performance of their drug products in the under‐represented sex via additional studies. In this work, we describe the case of Dextromethorphan modified release tablets where the gender effect on the product performance was evaluated by physiologically based pharmacokinetic (PBPK) modeling approach. We have compared the drug product's performance by population simulations considering four different scenarios. The data from all‐male population (from in house Pharmacokinetic [PK] BE studies) was considered as a reference and other scenarios were compared against the all‐male population data. In the first scenario, we made a comparison between all‐male (100% male) vs all‐female (100% female) population. Second scenario was as per agency’s requirements—equal proportion of male and female in the BE study. As an extreme scenario, 100% male vs 30:70 male:female was considered (higher females than males in the BE studies). Finally, as a more realistic scenario, 100% male versus 70:30 male:female was considered (lower females than males in the BE studies). Population PK followed by virtual BE was employed to demonstrate the similarity/differences in the drug product performance between the sexes. This approach can be potentially utilized to seek BE study waivers thus saving cost and accelerating the entry of the generic products to the market.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Therapeutic EquivalencyDextromethorphanDrugs, GenericModels, BiologicalTabletsHumansMaleFemaleDelayed-Action PreparationsSex FactorsAdult

Stichwörter der Autor:innen

PBPKbioequivalencedextromethorphangastroplusgender effect

Substanzen

DextromethorphanDrugs, GenericTabletsDelayed-Action Preparations

Autor:innen und Institutionen

  • Global Clinical Management, IPDO, Dr Reddy's Laboratories Ltd, Hyderabad, India.
  • Biopharmaceutics Group, Global Clinical Management, IPDO, Dr Reddy's Laboratories Ltd, Hyderabad, India.
  • Department of Biopharmaceutics and Bioequivalence, Global Clinical Management, IPDO, Dr Reddy's Laboratories Ltd, Hyderabad, India.

ORCID-Profile: Aditya Murthy, Tausif Ahmed

Förderung

  • Dr Reddy's Laboratories Ltd, Hyderabad, India

Zitieren

APA

Gundeti, M., Murthy, A., Jamdade, S., & Ahmed, T. (2024). Evaluating gender effect in the generic bioequivalence studies by physiologically based pharmacokinetic modeling – A case study of dextromethorphan modified release tablets. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.2389

Vancouver

Gundeti M, Murthy A, Jamdade S, Ahmed T. Evaluating gender effect in the generic bioequivalence studies by physiologically based pharmacokinetic modeling – A case study of dextromethorphan modified release tablets. Biopharmaceutics & Drug Disposition. 2024. doi:10.1002/bdd.2389

BibTeX
@article{Gundeti2024,
  author = {Gundeti, Manoj and Murthy, Aditya and Jamdade, Shubham and Ahmed, Tausif},
  title = {Evaluating gender effect in the generic bioequivalence studies by physiologically based pharmacokinetic modeling – A case study of dextromethorphan modified release tablets},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2024},
  doi = {10.1002/bdd.2389}
}
Kostenlos starten →